The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 19, 2025
Filed:
Jan. 07, 2022
Applicant:
Starton Therapeutics, Inc., Paramus, NJ (US);
Inventors:
Rod L. Hartwig, Sloatsburg, NY (US);
Arturo Serrano-Batista, Sloatsburg, NY (US);
James Oliver, Raleigh, NC (US);
Assignee:
Starton Therapeutics, Inc., Paramus, NJ (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/454 (2006.01); A61K 31/5377 (2006.01); A61K 47/02 (2006.01); A61K 47/12 (2006.01); A61K 47/32 (2006.01);
U.S. Cl.
CPC ...
A61K 31/454 (2013.01); A61K 31/5377 (2013.01); A61K 47/02 (2013.01); A61K 47/12 (2013.01); A61K 47/32 (2013.01);
Abstract
Provided are compositions comprising a stable solution of an immune-mediated inflammatory disease (IMID) agent, such as an immunomodulatory imide drug (IMiD) including, but not limited to, lenalidomide (LLD). More particularly, embodiments relate to stable solutions of IMiDs for parenteral use. Methods of preparing stable solutions of IMiDs are also provided. In some embodiments, methods of treating inflammatory disorders and cancer(s) by parenteral use of stable IMiD solutions, and formulations thereof, are provided.